Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio

Johnson & Johnson is highlighted as a compelling dividend investment with a 2.02% yield, outperforming both its industry (1.93%) and the S&P 500 (1.41%). The company has increased its dividend annually over the past 5 years with an average increase of 5.37%, and maintains a sustainable 49% payout ratio. With solid earnings growth projected at 7.41% for 2026, JNJ is rated as a Hold (Zacks Rank #3), making it suitable for income-focused investors seeking stable cash flow from an established healthcare leader.